FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Thursday

 

Oxidative Stress And MS: What's The Link Between The Two? The Details, Inside: VIDEO






























With the emergence of MS being put on record this year, how does oxidative stress contribute to it's prevalence? Can this be considered as one of the culprits of the said disease? Here's what experts have to say (Photo : Dan Kitwood/Getty Images)

A new study about patients with progressive MS has recently found that a steroid treatment can potentially be beneficial by decreasing oxidative stress in the cerebrospinal fluid. It was found that oxidative stress (OS) is currently perceived as a major subject for being a biomarker for the prevalence of MS and its progression. Consequently, experts have noted that these studies are showing a significant success rate at stopping and reversing the damage done by the demyelination caused by OS.

Oxidative Stress And MS: What's The Link?

According to reports revealed by Health Line, oxidative stress has long been considered as the prime mover of the inflammation which is also neurodegenerative. In their recent studies, experts have highly emphasized that OS is also an essential factor that is basically associated with demyelination in MS.

Furthermore, as per MS News Today, researchers have found that the human body allegedly possesses certain mechanisms, such as antioxidant responses, which in turn, counteracts the accumulation of damaging proteins that result from oxidative stress. As a matter of fact, antioxidant responses are deemed as an important mechanism for maintaining homeostasis and viability. Experts believe that through the investigation of these mechanisms in the cerebrospinal fluid (CSF) of MS patients may potentially give indications as to the interplay of disease progression, chronic inflammation, and response to treatment.

The research team observed that radicals were present in MS patients' CSF, while absent in healthy controls. Ultimately, antioxidants such as vitamin C, vitamin E, berries, and juices have typically been used to neutralize free radicals and prevent the damage they cause. However, although significant numbers of researches have already shown various therapeutic effects based on antioxidants, using OS markers as biomarkers of MS severity or relapse could be a helpful diagnostic tool.Experts claim that due to their ability to reduce OS, adding antioxidants to immunotherapy may be beneficial for people with MS.

Story Source: The above story is based on materials provided by ITECHPOST
Note: Materials may be edited for content and length

Labels:



Go to Newer News Go to Older News